Leptin and paraoxonase activity in cord blood from obese mothers

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 13, 2014, Pages 1353-1356

  Ferretti, G ^a   Cester, A M ^b   Bacchetti, T ^b   Raffaelli, F ^b   Vignini, A ^b   Orici, F ^b   Martino, C ^b   Tranquilli, A ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Department of Clinical Experimental Science and Odontostomatology ^*  (Italy)

Author keywords

Leptin; Obesity; Oxidative damage; Oxidized LDL; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; LEPTIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PON1 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MATERNAL BLOOD; MOTHER; NEWBORN; OBESITY; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; FETUS BLOOD; PREGNANCY COMPLICATION;

ADULT; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; HUMANS; LEPTIN; OBESITY; OXIDATIVE STRESS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84905512345     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.858319     Document Type: Article

References (34)

1. Codoñer-Franch P, Valls-Bellés V, Arilla-Codoñer A, Alonso-Iglesias E. Oxidant mechanisms in childhood obesity: the link between inflammation and oxidative stress. Transl Res 2011;158: 369-84.
2. Atabek ME, Vatansev H, Erkul I. Oxidative stress in childhood obesity. J Pediatr Endocrinol Metab 2004;17:1063-8.
3. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-61.
4. Ferretti G, Bacchetti T, Masciangelo S, Bicchiega V. HDLparaoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects. Obesity 2010;18:1079-84.
5. Savini I, Catani MV, Evangelista D, et al. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci 2013;14:10497-538.
6. Joint FAO/WHO expert consultation on diet, nutrition and the prevention of chronic diseases. Diet, nutrition, and the prevention of chronic diseases. World Health Organ Tech Rep Ser 2003;916:58-63.
7. Li M, Sloboda DM, Vickers MH. Maternal obesity and developmental programming of metabolic disorders in offspring: evidence from animal models. Experiment Diabetes Res 2011;2011:9. Article ID. 592408. doi: 10.1155/2011/592408.
8. Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991;286:152-4.
9. Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by highdensity lipoprotein associated paraoxonase. Atherosclerosis 1993; 104:129-35.
10. Mackness B, Mackness M. Anti-inflammatory properties of paraoxonase-1 in atherosclerosis. Adv Exp Med Biol 2010;660: 143-51.
11. Mastorikou M, Mackness B, Liu Y, Mackness M. Glycation of paraoxonase-1 inhibits its activity and impairs the ability of highdensity lipoprotein to metabolize membrane lipid hydroperoxides. Diabet Med 2008;25:1049-55.
12. Navab M, Imes SS, Hama SY, et al. Monocyte transmigration induced by modification of low density lipoprotein in co-cultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991;88:2039-46.
13. Mackness B, Hine D, Liu Y, et al. Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. Biochem Biophys Res Commun 2004;318:680-3.
14. Ferretti G, Bacchetti T, Masciangelo S, et al. Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome. Dis Model Mech 2012;5:698-705.
15. Ferretti G, Bacchetti T, Moroni C, et al. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab 2005;90:1728-33.
16. Krzystek-Korpacka M, Patryn E, Hotowy K, et al. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress. Adv Clin Exp Med 2013;22:229-236.
17. Payne GA, Tune JD, Knudson JD. Leptin-induced endothelial dysfunction: a target for therapeutic interventions. Curr Pharm Des 2013 [Epub ahead of print].
18. Lepercq J, Hauguel De Mouzo S. Leptin during pregnancy. J Gynecol Obstet Biol Reprod (Paris) 2002;31:167-72.
19. Lepercq J, Challier JC, Guerre-Millo M, et al. Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab 2001;86:2409-13.
20. Holvoet P, Stassen JM, Van Cleemput J, et al. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998;18:100-7.
21. Matsuda J, Yokota I, Iida M, et al. Serum leptin concentration in cord blood: relationship to birth weight and gender. J Clin Endocrinol Metab 1997;8:1642-4.
22. Abuhandan M, Cakmak A, Taski{dotless}n A, et al. The effect of age on the paraoxonase and arylesterase activity of pregnant mothers and their infants. J Clin Lab Anal 2012;26:302-6.
23. Gelisgen R, Genc H, Kayali R, et al. Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res Clin Pract 2011; 94:404-9.
24. Stefanović A, Ardalic D, Kotur-Stevuljević J, et al. Longitudinal changes in PON1 activities, PON1 phenotype distribution and oxidative status throughout normal pregnancy. Reprod Toxicol 2012;33:20-6.
25. Bastida S, Sánchez-Muniz FJ, Cuesta C, et al. Male and female cord blood lipoprotein profile differences throughout the termperiod. J Perinat Med 1997;25:184-91.
26. Dolphin PJ, Breckenridge WC, Dolphin MA, Tan MH. The lipoproteins of human umbilical cord blood apolipoprotein and lipid levels. Atherosclerosis 1984;51:109-22.
27. Sreckovic I, Birner-Gruenberger R, Obrist B, et al. Distinct composition of human fetal HDL attenuates its anti-oxidative capacity. Biochim Biophys Acta 2013;1831:737-46.
28. Sivan E, Mazaki-Tovi S, Pariente C, et al. Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab 2003;88:5656-60.
29. Weyermann M, Beermann C, Brenner H, Rothenbacher D. Adiponectin and leptin in maternal serum, cord blood, and breast milk. Clin Chem 2006;52:2095-102.
30. Brynhildsen J, Sydsjö G, Blomberg M, et al. Leptin and adiponectin in cord blood from children of normal weight, overweight and obese mothers. Acta Paediatr 2013;102:620-4.
31. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155-61.
32. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006;207: 12-22.
33. Yamagishi SI, Edelstein D, Du XL, et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001;276: 25096-100.
34. Beltowski J, Wojcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for roatherogenic effect of chronic hyperleptinemia. Atherosclerosis 2003;170:21-29.